Anas Ali
- Writer
- Mumbai
- 4 Articles
Anas writes on IT, Deep Tech, AI and pharmaceuticals with a public markets lens. He studied journalism from the Indian Institute of Journalism & New Media, Bengaluru. In his free time, he builds Legos, reads about the Renaissance and chats about Star Wars.
Featured Story
Cipla’s conservative approach is beginning to hurt
The drugmaker’s reluctance to part with cash may have given it one of the strongest balance sheets in Indian pharma, but investors are increasingly rewarding risk takers.
26 Jul 2026
